Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes

[1]  Harm HogenEsch,et al.  Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants , 2013, Front. Immun..

[2]  Leaf Huang,et al.  Corrigendum to "Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens" [Vaccine 30 (13) (2012) 2256-2272] , 2012 .

[3]  M. Kool,et al.  Alum adjuvant: some of the tricks of the oldest adjuvant. , 2012, Journal of medical microbiology.

[4]  R. Fujiwara,et al.  Canine Skin and Conjunctival Swab Samples for the Detection and Quantification of Leishmania infantum DNA in an Endemic Urban Area in Brazil , 2012, PLoS neglected tropical diseases.

[5]  Leaf Huang,et al.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. , 2012, Vaccine.

[6]  C. Reed,et al.  Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. , 2012, Vaccine.

[7]  I. Frazer,et al.  Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer. , 2011, Current opinion in virology.

[8]  C. Granier,et al.  Mimotopes of mutalysin-II from Lachesis muta snake venom induce hemorrhage inhibitory antibodies upon vaccination of rabbits , 2011, Peptides.

[9]  V. Schijns,et al.  Trends in vaccine adjuvants , 2011, Expert review of vaccines.

[10]  ScienceDirect.  Current opinion in virology , 2011 .

[11]  Jagadeesh Bayry,et al.  Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. , 2009, Trends in pharmacological sciences.

[12]  M. Teixeira,et al.  Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi. , 2009, Veterinary immunology and immunopathology.

[13]  C. Granier,et al.  Immunodiagnosis of human neurocysticercosis using a synthetic peptide selected by phage-display. , 2009, Clinical immunology.

[14]  P. Marrack,et al.  Towards an understanding of the adjuvant action of aluminium , 2009, Nature Reviews Immunology.

[15]  R. Gazzinelli,et al.  Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. , 2008, Vaccine.

[16]  P. Hotez,et al.  Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults. , 2008, Vaccine.

[17]  T. Coetzer,et al.  Phage display: a useful tool for malaria research? , 2008, Trends in parasitology.

[18]  J. Alvar,et al.  Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment. , 2007, The American journal of tropical medicine and hygiene.

[19]  C. B. Palatnik-de-Sousa,et al.  Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil. , 2007, Vaccine.

[20]  M. F. Madeira,et al.  Mixed infection with Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi in a naturally infected dog from Rio de Janeiro, Brazil. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[21]  H. Robinson,et al.  T cell vaccines for microbial infections , 2005, Nature Medicine.

[22]  G. Fragoso,et al.  Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. , 2004, Veterinary immunology and immunopathology.

[23]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[24]  M. Patarroyo,et al.  Immunodiagnosis of parasitic diseases with synthetic peptides. , 2003, Current protein & peptide science.

[25]  C. Ferro,et al.  PCR para la confirmación de transmisión experimental de Leishmania chagasi a hámster sano por picadura de Lutzomyia longipalpis (Diptera: Psychodidae) , 2003 .

[26]  L. Munstermann,et al.  [PCR as a tool in confirming the experimental transmission of Leishmania chagasi to hamsters by Lutzomyia longipalpis (Diptera:Psychodidae)]. , 2003, Biomedica : revista del Instituto Nacional de Salud.

[27]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[28]  D. Sacks,et al.  The immunology of susceptibility and resistance to Leishmania major in mice , 2002, Nature Reviews Immunology.

[29]  W. Egan,et al.  Corrigendum to “Aluminum salts in vaccines—US perspective” [Vaccine 20 (Suppl. 2) (2002) S18–S23] , 2002 .

[30]  D. Laune,et al.  Application of the Spot method to the identification of peptides and amino acids from the antibody paratope that contribute to antigen binding. , 2002, Journal of immunological methods.

[31]  Javier Moreno,et al.  Canine leishmaniasis: epidemiological risk and the experimental model. , 2002, Trends in parasitology.

[32]  Paul Richman,et al.  Aluminum salts in vaccines--US perspective. , 2002, Vaccine.

[33]  J. Alvar,et al.  Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells. , 2000, Research in veterinary science.

[34]  D. Laune,et al.  Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display. Role of sequences flanking thebinding motif. , 2000, European journal of biochemistry.

[35]  M. Marzochi,et al.  Experimental infection of canine peritoneal macrophages with visceral and dermotropic Leishmania strains. , 1999, Memorias do Instituto Oswaldo Cruz.

[36]  X. Fang,et al.  Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type 2 , 1997, Clinical and diagnostic laboratory immunology.

[37]  X. Gong,et al.  Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage. , 1996, Journal of molecular biology.

[38]  R. Tesh,et al.  Leishmaniases of the New World: current concepts and implications for future research , 1993, Clinical Microbiology Reviews.

[39]  C. Boulin,et al.  Automated multiple peptide synthesis. , 1992, Peptide research.

[40]  R. Harland,et al.  Localized expression of a Xenopus POU gene depends on cell-autonomous transcriptional activation and induction-dependent inactivation. , 1992, Development.

[41]  N. Garçon,et al.  Universal vaccine carrier. Liposomes that provide T-dependent help to weak antigens. , 1991, Journal of immunology.

[42]  G. Gregoriadis.  Immunological adjuvants: a role for liposomes. , 1990, Immunology today.

[43]  R. Tesh,et al.  A review of the geographic distribution and epidemiology of leishmaniasis in the New World. , 1989, The American journal of tropical medicine and hygiene.

[44]  M. Gramiccia,et al.  Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment , 1987, Medical and veterinary entomology.

[45]  W. D. de Souza,et al.  Canine visceral leishmaniasis in Rio de Janeiro, Brazil. Clinical, parasitological, therapeutical and epidemiological findings (1977-1983). , 1985, Memorias do Instituto Oswaldo Cruz.

[46]  C. Jenkin,et al.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. , 1978, Immunochemistry.

[47]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[49]  A. Allison,et al.  Liposomes as immunological adjuvants , 1974, Nature.

[50]  S. Kinsky,et al.  Antibody formation in response to liposomal model membranes sensitized with N-substituted phosphatidylethanolamine derivatives. , 1974, Biochemistry.